Small Molecule Compounds for Drug Designs
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 122
Special Issue Editor
Interests: small-molecule drugs; target molecules; drug design; cellular biochemistry; machine learning; molecular model
Special Issue Information
Dear Colleagues,
In the field of drug development, small-molecule compounds still play a central role in the development of effective therapeutics. In this Special Issue, we present the latest trends and prospects for the development of new drugs through advanced and creative research.
We welcome research papers on a wide range of topics, including the identification of new target molecules, synthesis of small-molecule drugs using rational design methods and innovative chemical approaches, the evaluation of their effects in bioassays and animal models, and their clinical application. We also look forward to sharing new insights into improving the efficiency of the drug design process, with a focus on methods utilizing advanced technologies such as computational chemistry and machine learning.
We hope that this Special Issue will provide a forum for a diverse group of pharmaceutical researchers, chemists and life scientists to collaborate and build on the current and comprehensive knowledge of small-molecule drugs. We hope that this Special Issue will help foster innovative progress in the development of new medicines and promote collaborative research in industry and academia.
We look forward to receiving valuable research papers from our contributors.
Dr. Hideki Tatsukawa
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- small-molecule drugs
- drug discovery
- synthetic drugs
- medicinal chemistry
- computational chemistry
